Recombinant PODXL anticorps (AA 310-447)

N° du produit ABIN7873806

L’anticorps anti-PODXL Monoclonal Souris est utilisé pour la détection de PODXL dans des échantillons de Humain. Il a été validé pour ELISA.

Aperçu rapide pour Recombinant PODXL anticorps (AA 310-447) (ABIN7873806)

Antigène: PODXL (Podocalyxin-Like (PODXL))

Type d'anticorp: Recombinant Antibody

Reactivité: Humain

Hôte: Souris

Clonalité: Monoclonal

Conjugué: Cet anticorp PODXL est non-conjugé

Application: ELISA

Classe de qualité: Carrier-free

Clone: RPODXL-2184

Détail du produit anti-PODXL anticorps

Épitope: AA 310-447

Fonction: Recombinant Podocalyxin Antibody (azide and preservative free)

Purification: Protein G affinity chromatography

Immunogène: A portion of amino acids 310-447 from the human protein was used as the immunogen for the recombinant Podocalyxin antibody.

Isotype: IgG1, kappa

Information d'application

Indications d'application: Optimal dilution of the recombinant Podocalyxin antibody should be determined by the researcher.

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 1 mg/mL

Buffer: 1 mg/mL in 1X PBS, BSA free, sodium azide free

Agent conservateur: Azide free

Stock: 4 °C,-20 °C

Stockage commentaire: Store the recombinant Podocalyxin antibody at 2-8oC (with azide) or aliquot and store at -20oC or colder (without azide).

Détails sur PODXL

Antigène: PODXL (Podocalyxin-Like (PODXL))

Autre désignation: Podocalyxin

Sujet: Podocalyxin is a member of the CD34 transmembrane sialomucin family. It is over-expressed on the podocyte foot projections and plays essential roles in kidney development and homeostasis, blood filtration and urine formation. It is also expressed on vascular endothelia, hematopoietic progenitors and a subset of neurons. Overexpression of podocalyxin may be linked to more aggressive tumor behavior. Podocalyxin antibody can identify podocytes in the urine (podocyturia) that may indicate glomerular disease, pre-eclampsia, and other kidney pathology.

UniProt: O00592

Pathways: Tube Formation